3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
50
Recruiting
12
Terminated
9
Active not recruiting
5
Unknown
4
Withdrawn
1
Suspended
1
Not yet recruiting
1
Approved for marketing
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Leukemia, Myeloid, Acute
1
Interventions
venetoclax
25
Azacitidine
23
Cytarabine
12
fludarabine
11
Specimen Handling
9
Biopsy
7
Busulfan
6
Melphalan
5
Daunorubicin
5
Thiotepa
4
Decitabine
4
Cyclophosphamide
4
selinexor
3
olutasidenib
3
gilteritinib
3
Whole-Body Irradiation
3
Tacrolimus
3
Idarubicin
3
Homoharringtonine
3
treosulfan
2
revumenib
2
fludarabine phosphate
2
decitabine and cedazuridine drug combination
2
Stem Cell Transplantation
2
Maintenance
2
Lymphatic Irradiation
2
Leukapheresis
2
Injections
2
Granulocyte Colony-Stimulating Factor
2
Drug Therapy
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Leukemia, Myeloid, Acute
×
Gemtuzumab
×
Clear all
NCT05662904
2025-03-14
GALAXY33
German Cancer Research Center
Phase 1
Not yet recruiting
12 enrolled